What's Going On With BELLUS Health's Stock Today?
BELLUS Health Inc (NASDAQ: BLU) is trading higher Monday after the company announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractory chronic cough.
The stock is experiencing high volatility, trading as high as $4.78 and as low as $3.63 in today's session.
